In vivo base modifying reduces cholesterol
News in Brief
Released: 11 December 2023
Nature Biotechnology
volume 41, page 1665 (2023 )Cite this post
The very first 'one-and-done' base modifying medication in the body has actually caused dose-dependent cholesterol decreases in i...